Go to deals
Healthcare

Adventum has been acquired by Humana

Humana, a leading Swedish provider of personal assistance services, has acquired Adventum, a specialized care provider offering support and care for children with social and psychiatric problems. Financial terms of this transaction have not been disclosed.

Humana is focused on elderly care, individual and family care, residential arrangements offering support and services for persons with certain functional impairments, as well as schools for students with disabilities.

This acquisition is an important step for Humana in developing its business unit Individual and Family that includes Baggium Care and Treatment, Tian Group and K REHAB. Adventum is a fast-growing, high quality company in an exciting market that is in the initial consolidation phase.

Oaklins' team in Sweden advised the seller in this transaction.

Parties

Talk to the deal team

Adel Koubaa

Managing Partner
Stockholm, Sweden
Oaklins Sweden

Related deals

Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.
Healthcare

Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.

Dimainvest S.r.l. has initiated a voluntary public tender offer for the shares of Shedir Pharma Group S.p.A.

Learn more
Afric Phar has been acquired by Pharma Capital
Healthcare

Afric Phar has been acquired by Pharma Capital

Pharma Capital S.A. has acquired a significant stake in the Moroccan pharmaceutical group Afric Phar, which includes leading companies Afric Phar, Pharmis and Partner Lab, from the Chaoui family, in one of the largest transactions in the Moroccan pharmaceutical sector.

Learn more
Xiel Limited has been acquired by MIS Healthcare
Private Equity | Healthcare

Xiel Limited has been acquired by MIS Healthcare

MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.

Learn more